Evidence map›Paper›PMID 22954328›Full record

ArticleEpidemiology and infection2013

The immune response to tuberculosis infection in the setting of Helicobacter pylori and helminth infections.

S Perry, A H Chang, L Sanchez, S Yang, T D Haggerty, J Parsonnet

Registry-linked trialAbstract read
In one paragraph

Article in Epidemiology and infection, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02740140 (Epidemiology of H. Pylori Transmission and Immunoepidemiology of Concomitant Infections), which is not on this map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02740140 completednot on this map

Epidemiology of H. Pylori Transmission and Immunoepidemiology of Concomitant Infections

TypeobservationalSponsorStanford UniversityRan2008 to 2013Enrolled1,750ConditionsCommunicable Diseases
3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. The Interplay betweenClinics and practice · 2024
    Review
  5. Review
  6. Review
  7. Review
  8. Review
  9. Article
  10. Review
  11. Review
  12. Tuberculosis Comorbidity with Communicable and Noncommunicable Diseases.Cold Spring Harbor perspectives in medicine · 2015
    Review
  13. Article
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

S PerryStanford University School of Medicine, Division of Infectious Diseases and Geographic Medicine, Stanford, CA, USA. shnperry@stanford.edu
A H Chang
L Sanchez
S Yang
T D Haggerty
J Parsonnet

Funding

EPIDEMIOLOGY OF HELICOBACTER PYLORI TRANSMISSIONR01AI042801 · NIAID · STANFORD UNIVERSITY · PI PARSONNET, JULIE · 1999 to 2010
$6.2M
Predictors of tuberculosis by stage of insulin resistanceK23AI091688 · NIAID · STANFORD UNIVERSITY · PI CHANG, ALICIA HSIN-MING · 2011 to 2015
$666k
NIAID NIH HHS K23 AI091688NIAID NIH HHS K23-AI091688-02NIAID NIH HHS R01 AI042801PHS HHS K23-054443PHS HHS R01-04801
6 · The paper itself

Abstract

We screened 176 healthy, adult (aged 18-55 years) US refugees from tuberculosis (TB)-endemic countries to evaluate whether cytokine responses to latent TB infection (LTBI) are modified in the setting of concurrent H. pylori and helminth infection. As measured by the Quantiferon-TB GOLD interferon-γ release assay, a total 38 (22%) subjects had LTBI, of which 28 (74%) also were H. pylori seropositive and/or helminth infected. Relative to ten subjects with LTBI only, 16 subjects with concurrent H. pylori infection had significantly elevated levels of IFN-γ, and nine subjects with both H. pylori and helminth infection had significantly elevated levels of IFN-γ, IL-2, IL-13, and IL-5. H. pylori is associated with enhanced IFN-γ responses to TB, even in the setting of concurrent helminth infection. Efficacy of TB vaccines may vary with the co-existence of these three infections in the developing world.

Indexed as

AdolescentAdultCoinfectionCross-Sectional StudiesFemaleHelicobacter InfectionsHelicobacter pyloriHelminthiasisHumansInterferon-gammaInterleukin-13Interleukin-2Interleukin-5Latent TuberculosisMaleMiddle AgedInterferon-gammaInterleukin-13Interleukin-2Interleukin-5

Identifiers

PMID22954328
PMCPMC3785541

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.